Hollis Showalter
ann arbor, MichiganOrganic and heterocyclic synthesis methodologies
Synthetic modification of natural products
Designing in physicochemical properties to high-throughput screen hits that confer "drugability" (e.g., conformity to Lipinski rules, absence of toxicophores)
Development of structure-activity relationships (SAR) to derive compounds with optimal pharmacokinetic and metabolic profiles toward the initiation of in vivo studies
Medicinal chemistry of inhibitors of protein kinases, principally PKC, EGFr, PDGFr, FGFr, VEGFr, c-Src, and therapeutic application to proliferative processes (cancer, restenosis, angiogenesis, and inflammatory diseases)
Medicinal chemistry of inhibitors of deubiquitinases and application to haematologic cancers
Medicinal chemistry of antibacterial agents; new agents for tuberculosis
Early-stage drug development
Chemistry
Unlock Full Profile
Direct contact details on file
Use 1 credit to reveal Hollis's full profile, including contact information, credentials, and complete work history. If they don't respond within 5 days, your credit is refunded.